Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Virus Research
- Vol. 115 (1) , 85-90
- https://doi.org/10.1016/j.virusres.2005.07.010
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical relevance of amphiregulin and VEGF in primary breast cancersInternational Journal of Cancer, 2004
- Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent mannerCellular Signalling, 2004
- Nasopharyngeal carcinomasEuropean Journal Of Cancer, 2003
- Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1Laboratory Investigation, 2003
- Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implicationsThe Lancet Oncology, 2001
- Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cellsProceedings of the National Academy of Sciences, 2001
- The Relationship Between Microvessel Density, the Expression of Vascular Endothelial Growth Factor (VEGF), and the Extension of Nasopharyngeal CarcinomaThe Laryngoscope, 2000
- Prognostic Significance of Vascular Endothelial Growth Factor Protein Levels in Oral and Oropharyngeal Squamous Cell CarcinomaJournal of Clinical Oncology, 2000
- Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinomaCancer, 2000
- The vascular endothelial growth factor family of polypeptidesJournal of Cellular Biochemistry, 1991